The potential of the microbiota to influence vaccine responses

Journal of Leukocyte Biology

Volumn 103, Issue 2, 2018, Pages 225-231

  Lynn, David J ^a,b   Pulendran, Bali ^c  

^a SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibiotics; antibody; B cell; short chain fatty acids; T cell

Indexed keywords

ADJUVANT; ANTIBIOTIC AGENT; VACCINE; ANTIINFECTIVE AGENT;

DRUG MECHANISM; DYSBIOSIS; HUMAN; IMMUNE DYSREGULATION; IMMUNITY; INTESTINE FLORA; METABOLITE; MICROBIOME; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VACCINATION; ANIMAL; DRUG EFFECT; GERMFREE ANIMAL; IMMUNOLOGY; MICROBIOLOGY; MOUSE; VACCINE IMMUNOGENICITY;

ANIMALS; ANTI-BACTERIAL AGENTS; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; GERM-FREE LIFE; HUMANS; IMMUNITY; IMMUNOGENICITY, VACCINE; MICE; T-LYMPHOCYTES; VACCINES;

EID: 85041009023     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.5MR0617-216R     Document Type: Review

References (69)

1. Andre, F. E., Booy, R., Bock, H. L., Clemens, J., Datta, S. K., John, T. J., Lee, B. W., Lolekha, S., Peltola, H., Ruff, T. A., Santosham, M., Schmitt, H. J. (2008) Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull. World Health Organ. 86, 140–146.
2. Siegrist, C. (2008) Vaccine immunology. In Vaccines: Expert Consult. 5th ed. (S. Plotkin, ed.), Saunders Elsevier, Philadelphia, 17–36.
3. Pulendran, B. (2009) Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol. 9, 741–747.
4. Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., Kennedy, K., Wu, H., Bennouna, S., Oluoch, H., Miller, J., Vencio, R. Z., Mulligan, M., Aderem, A., Ahmed, R., Pulendran, B. (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116–125.
5. Nakaya, H. I., Hagan, T., Duraisingham, S. S., Lee, E. K., Kwissa, M., Rouphael, N., Frasca, D., Gersten, M., Mehta, A. K., Gaujoux, R., Li, G. M., Gupta, S., Ahmed, R., Mulligan, M. J., Shen-Orr, S., Blomberg, B. B., Subramaniam, S., Pulendran, B. (2015) Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures. Immunity 43, 1186–1198.
6. Payton, T., Girgenti, D., Frenck, R. W., Patterson, S., Love, J., Razmpour, A., Sidhu, M. S., Emini, E. A., Gruber, W. C., Scott, D. A. (2013) Immunogenicity, safety and tolerability of 3 lots of 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in the United States. Pediatr. Infect. Dis. J. 32, 871–880.
7. Finan, C., Ota, M. O., Marchant, A., Newport, M. J. (2008) Natural variation in immune responses to neonatal mycobacterium bovis Bacillus Calmette-Guerin (BCG) vaccination in a cohort of Gambian infants. PLoS One 3, e3485.
8. Zhang, L., Prietsch, S. O., Axelsson, I., Halperin, S. A. (2012) Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst. Rev. 3, CD001478.
9. Dye, C. (2013) Making wider use of the world’s most widely used vaccine: bacille Calmette-Guerin revaccination reconsidered. J. R. Soc. Interface 10, 20130365.
10. Ferreira, R. B. R., Antunes, L. C. M., Finlay, B. B. (2010) Should the human microbiome be considered when developing vaccines? PLoS Pathog. 6, e1001190.
11. Grassly, N. C., Kang, G., Kampmann, B. (2015) Biological challenges to effective vaccines in the developing world. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370, 20140138.
12. Mentzer, A. J., O’Connor, D., Pollard, A. J., Hill, A. V. (2015) Review article: searching for the human genetic factors standing in the way of universally effective vaccines. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370,20140341.
13. Hodgins, D. C., Shewen, P. E. (2012) Vaccination of neonates: problem and issues. Vaccine 30, 1541–1559.
14. Jamieson, A. M. (2015) Influence of the microbiome on response to vaccination. Hum. Vaccin. Immunother. 11, 2329–2331.
15. Nguyen, Q. N., Himes, J. E., Martinez, D. R., Permar, S. R. (2016) The impact of the gut microbiota on humoral immunity to pathogens and vaccination in early infancy. PLoS Pathog. 12, e1005997.
16. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R. (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241.
17. Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., Khan, M. T., Zhang, J., Li, J., Xiao, L., Al-Aama, J., Zhang, D., Lee, Y. S., Kotowska, D., Colding, C., Tremaroli, V., Yin, Y., Bergman, S., Xu, X., Madsen, L., Kristiansen, K., Dahlgren, J., Wang, J. (2015) Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 852.
18. Madan, J. C., Hoen, A. G., Lundgren, S. N., Farzan, S. F., Cottingham, K. L., Morrison, H. G., Sogin, M. L., Li, H., Moore, J. H., Karagas, M. R. (2016) Association of cesarean delivery and formula supplementation with the intestinal microbiome of 6-week-old infants. JAMA Pediatr. 170, 212–219.
19. Fouhy, F., Ross, R. P., Fitzgerald, G. F., Stanton, C., Cotter, P. D. (2012) Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes 3, 203–220.
20. Zhernakova, A., Kurilshikov, A., Bonder, M. J., Tigchelaar, E. F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A. V., Falony, G., Vieira-Silva, S., Wang, J., Imhann, F., Brandsma, E., Jankipersadsing, S. A., Joossens, M., Cenit, M. C., Deelen, P., Swertz, M. A., LifeLines Cohort Study Group, Weersma, R. K., Feskens, E. J., Netea, M. G., Gevers, D., Jonkers, D., Franke, L., Aulchenko, Y. S., Huttenhower, C., Raes, J., Hofker, M. H., Xavier, R. J., Wijmenga, C., Fu, J. (2016) Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569.
21. Vangay, P., Ward, T., Gerber, J. S., Knights, D. (2015) Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17, 553–564.
22. Doan, T., Arzika, A. M., Ray, K. J., Cotter, S. Y., Kim, J., Maliki, R., Zhong, L., Zhou, Z., Porco, T. C., Vanderschelden, B., Keenan, J. D., Lietman, T. M. (2017) Gut microbial diversity in antibiotic-naive children after systemic antibiotic exposure: a randomized controlled trial. Clin. Infect. Dis. 64, 1147–1153.
23. Azad, M. B., Konya, T., Persaud, R. R., Guttman, D. S., Chari, R. S., Field, C. J., Sears, M. R., Mandhane, P. J., Turvey, S. E., Subbarao, P., Becker, A. B., Scott, J. A., Kozyrskyj, A. L.; CHILD Study Investigators. (2015) Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG. 123, 983–993.
24. Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., Gewirtz, A. T. (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228–231.
25. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., Gordon, J. I. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031.
26. Russell, S. L., Gold, M. J., Hartmann, M., Willing, B. P., Thorson, L., Wlodarska, M., Gill, N., Blanchet, M. R., Mohn, W. W., McNagny, K. M., Finlay, B. B. (2012) Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 13, 440–447.
27. Gomez de Agüero, M., Ganal-Vonarburg, S. C., Fuhrer, T., Rupp, S., Uchimura, Y., Li, H., Steinert, A., Heikenwalder, M., Hapfelmeier, S., Sauer, U., McCoy, K. D., Macpherson, A. J. (2016) The maternal microbiota drives early postnatal innate immune development. Science 351, 1296–1302.
28. Kuppala, V. S., Meinzen-Derr, J., Morrow, A. L., Schibler, K. R. (2011) Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J. Pediatr. 159, 720–725.
29. Honda, K., Littman, D. R. (2016) The microbiota in adaptive immune homeostasis and disease. Nature 535, 75–84.
30. Schirmer, M., Smeekens, S. P., Vlamakis, H., Jaeger, M., Oosting, M., Franzosa, E. A., ter Horst, R., Jansen, T., Jacobs, L., Bonder, M. J., Kurilshikov, A., Fu, J., Joosten, L. A., Zhernakova, A., Huttenhower, C., Wijmenga, C., Netea, M. G., Xavier, R. J. (2016) Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167, 1897.
31. Woo, P. C., Tsoi, H. W., Wong, L. P., Leung, H. C., Yuen, K. Y. (1999) Antibiotics modulate vaccine-induced humoral immune response. Clin. Diagn. Lab. Immunol. 6, 832–837.
32. Tauber, S. C., Nau, R. (2008) Immunomodulatory properties of antibiotics. Curr. Mol. Pharmacol. 1, 68–79.
33. Lamousé-Smith, E. S., Tzeng, A., Starnbach, M. N. (2011) The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice. PLoS One 6, e27662.
34. Uchiyama, R., Chassaing, B., Zhang, B., Gewirtz, A. T. (2014) Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J. Infect. Dis. 210, 171–182.
35. Oh, J. Z., Ravindran, R., Chassaing, B., Carvalho, F. A., Maddur, M. S., Bower, M., Hakimpour, P., Gill, K. P., Nakaya, H. I., Yarovinsky, F., Sartor, R. B., Gewirtz, A. T., Pulendran, B. (2014) TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41, 478–492.
36. Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., Aderem, A. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099–1103.
37. Pabst, O., Hornef, M. (2014) Gut microbiota: a natural adjuvant for vaccination. Immunity 41, 349–351.
38. Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., Villinger, F., Murthy, N., Steel, J., Jacob, J., Hogan, R. J., García-Sastre, A., Compans, R., Pulendran, B. (2011) Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470, 543–547.
39. Kim, D., Kim, Y. G., Seo, S. U., Kim, D. J., Kamada, N., Prescott, D., Philpott, D. J., Rosenstiel, P., Inohara, N., Núñez, G. (2016) Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin. Nat. Med. 22, 524–530.
40. Park, J. H., Kim, Y. G., McDonald, C., Kanneganti, T. D., Hasegawa, M., Body-Malapel, M., Inohara, N., Núñez, G. (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178, 2380–2386.
41. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., Foster, S. J., Moran, A. P., Fernandez-Luna, J. L., Nuñez, G. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease. J. Biol. Chem. 278, 5509–5512.
42. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., Gusovsky, F. (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689–10692.
43. Vatanen, T., Kostic, A. D., d’Hennezel, E., Siljander, H., Franzosa, E. A., Yassour, M., Kolde, R., Vlamakis, H., Arthur, T. D., Hämäläinen, A. M., Peet, A., Tillmann, V., Uibo, R., Mokurov, S., Dorshakova, N., Ilonen, J., Virtanen, S. M., Szabo, S. J., Porter, J. A., Lähdesmäki, H., Huttenhower, C., Gevers, D., Cullen, T. W., Knip, M., DIABIMMUNE Study Group, Xavier, R. J. (2016) Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 842–853.
44. Pulendran, B., Kumar, P., Cutler, C. W., Mohamadzadeh, M., Van Dyke, T., Banchereau, J. (2001) Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167, 5067–5076.
45. Zeng, M. Y., Inohara, N., Nuñez, G. (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 10, 18–26.
46. Fei, N., Zhao, L. (2013) An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 7, 880–884.
47. Tulstrup, M. V., Christensen, E. G., Carvalho, V., Linninge, C., Ahrné, S., Højberg, O., Licht, T. R., Bahl, M. I. (2015) Antibiotic treatment affects intestinal permeability and gut microbial composition in Wistar rats dependent on antibiotic class. PLoS One 10, e0144854.
48. Brenchley, J. M., Douek, D. C. (2012) Microbial translocation across the GI tract. Annu. Rev. Immunol. 30, 149–173.
49. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B. R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J. N., Hecht, F. M., Picker, L. J., Lederman, M. M., Deeks, S. G., Douek, D. C. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365–1371.
50. Cooke, K. R., Olkiewicz, K., Erickson, N., Ferrara, J. L. (2002) The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J. Endotoxin Res. 8, 441–448.
51. Caradonna, L., Amati, L., Magrone, T., Pellegrino, N. M., Jirillo, E., Caccavo, D. (2000) Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin Res. 6, 205–214.
52. Zeng, M. Y., Cisalpino, D., Varadarajan, S., Hellman, J., Warren, H. S., Cascalho, M., Inohara, N., Núñez, G. (2016) Gut microbiota-induced immunoglobulin G controls systemic infection by symbiotic bacteria and pathogens. Immunity 44, 647–658.
53. Buchta, C. M., Bishop, G. A. (2014) Toll-like receptors and B cells: functions and mechanisms. Immunol. Res. 59, 12–22.
54. Rosser, E. C., Oleinika, K., Tonon, S., Doyle, R., Bosma, A., Carter, N. A., Harris, K. A., Jones, S. A., Klein, N., Mauri, C. (2014) Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat. Med. 20, 1334–1339.
55. Dorrestein, P. C., Mazmanian, S. K., Knight, R. (2014) Finding the missing links among metabolites, microbes, and the host. Immunity 40, 824–832.
56. Rooks, M. G., Garrett, W. S. (2016) Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16, 341–352.
57. Kim, M., Qie, Y., Park, J., Kim, C. H. (2016) Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 20, 202–214.
58. Kim, M., Kim, C. H. (2017) Regulation of humoral immunity by gut microbial products. Gut Microbes [E-Pub ahead of print] 10.1080/19490976.2017.129931.
59. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., Rudensky, A. Y. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455.
60. Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., Tanoue, T., Imaoka, A., Itoh, K., Takeda, K., Umesaki, Y., Honda, K., Littman, D. R. (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485–498.
61. Gonzalez-Perez, G., Hicks, A. L., Tekieli, T. M., Radens, C. M., Williams, B. L., Lamousé-Smith, E. S. (2016) Maternal antibiotic treatment impacts development of the neonatal intestinal microbiome and antiviral immunity. J. Immunol. 196, 3768–3779.
62. Gonzalez-Perez, G., Lamousé-Smith, E. S. (2017) Gastrointestinal microbiome dysbiosis in infant mice alters peripheral CD8(+) T cell receptor signaling. Front. Immunol. 8, 265.
63. Huda, M. N., Lewis, Z., Kalanetra, K. M., Rashid, M., Ahmad, S. M., Raqib, R., Qadri, F., Underwood, M. A., Mills, D. A., Stephensen, C. B. (2014) Stool microbiota and vaccine responses of infants. Pediatrics 134, e362–e372.
64. Harris, V. C., Armah, G., Fuentes, S., Korpela, K. E., Parashar, U., Victor, J. C., Tate, J., de Weerth, C., Giaquinto, C., Wiersinga, W. J., Lewis, K. D. C., de Vos, W. M. (2016) The infant gut microbiome correlates significantly with rotavirus vaccine response in rural Ghana. J. Infect. Dis. 215, 34–41.
65. Salk, H. M., Simon, W. L., Lambert, N. D., Kennedy, R. B., Grill, D. E., Kabat, B. F., Poland, G. A. (2016) Taxa of the nasal microbiome are associated with influenza-specific IgA response to live attenuated influenza vaccine. PLoS One 11, e0162803.
66. Valdez, Y., Brown, E. M., Finlay, B. B. (2014) Influence of the microbiota on vaccine effectiveness. Trends Immunol. 35, 526–537.
67. Thaiss, C. A., Zmora, N., Levy, M., Elinav, E. (2016) The microbiome and innate immunity. Nature 535, 65–74.
68. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., Peng, Y., Zhang, D., Jie, Z., Wu, W., Qin, Y., Xue, W., Li, J., Han, L., Lu, D., Wu, P., Dai, Y., Sun, X., Li, Z., Tang, A., Zhong, S., Li, X., Chen, W., Xu, R., Wang, M., Feng, Q., Gong, M., Yu, J., Zhang, Y., Zhang, M., Hansen, T., Sanchez, G., Raes, J., Falony, G., Okuda, S., Almeida, M., LeChatelier, E., Renault, P., Pons, N., Batto, J. M., Zhang, Z., Chen, H., Yang, R., Zheng, W., Li, S., Yang, H., Wang, J., Ehrlich, S. D., Nielsen, R., Pedersen, O., Kristiansen, K., Wang, J. (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60.
69. Geva-Zatorsky, N., Sefik, E., Kua, L., Pasman, L., Tan, T. G., Ortiz-Lopez, A., Yanortsang, T. B., Yang, L., Jupp, R., Mathis, D., Benoist, C., Kasper, D. L. (2017) Mining the human gut microbiota for immunomodulatory organisms. Cell 168, 928–943.e11.